Using a discrete choice experiments to explore societal preferences for valuing new drugs for rare diseases
Abstract Background Rare diseases affect few people, but collectively they affect a substantial proportion of the population. Limited treatment options and the additional challenges of securing public funding make reimbursement decision making particularly complex, mainly due to the inherent evidenc...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2025-12-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s13023-025-04141-0 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|